Furthermore, the phosphorylation level of GSKβ and P70S6K downstream molecules was substantially reduced by crizotinb treatment (Fig. 6b), providing evidence that this compound affects aberrant cell signalling in ARMS cells by blocking AKT- and ERK-related pathways. Here, AKT1 is linked to alveolar rhabdomyosarcoma.